One crucial feature of almost all bacterial infections is the need for the
invading pathogen to reach a critical cell population density sufficient to
overcome host defences and establish the infection. Controlling the expres
sion of virulence determinants in concert with cell population density may
therefore confer a significant survival advantage on the pathogen such that
the host is overwhelmed before a defence response can be fully initiated.
Many different bacterial pathogens are now known to regulate diverse physio
logical processes including virulence in a cell-density-dependent manner th
rough cell-cell communication. This phenomenon, which relies on the interac
tion of a diffusible signal molecule (e.g. an N-acylhomoserine lactone) wit
h a sensor or transcriptional activator to couple gene expression with cell
population density, has become known as 'quorum sensing'. Although the siz
e of the 'quorum' is likely to be highly variable and influenced by the dif
fusibility of the signal molecule within infected tissues, nevertheless quo
rum-sensing signal molecules can be detected in vivo in both experimental a
nimal model and human infections. Furthermore, certain quorum-sensing molec
ules have been shown to possess pharmacological and immunomodulatory activi
ty such that they may function as virulence determinants per se. As a conse
quence, quorum sensing constitutes a novel therapeutic target for the desig
n of small molecular antagonists capable of attenuating virulence through t
he blockade of bacterial cell-cell communication.